Annalisa Jenkins

Chair Of The Board, FasterCures

Dr. Annalisa Jenkins is a life sciences thought leader with over 25 years of biopharmaceutical industry experience. She served as president and CEO of Dimension Therapeutics, a leading NASDAQ listed gene therapy company that was acquired by Ultragenyx in 2017.

Social Media

• LinkedIn